Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Hepatic Oncology|February 17, 2015
Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decadesSusanna V Ulahannan, Osama E Rahma, Austin G Duffy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2020
Early 3+3 Trial Dose-Escalation Phase I Clinical Trial Design and Suitability for Immune Checkpoint InhibitorsOsama E Rahma, Joshua E Reuss, Anita Giobbie-Hurder, et al.
Hepatology (Baltimore, Md.)|July 5, 2014
Earlier presentation and application of curative treatments in hepatocellular carcinomaSusanna V Ulahannan, Austin G Duffy, Timothy S McNeel, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 2021
Cytokine changes during immune-related adverse events and corticosteroid treatment in melanoma patients receiving immune checkpoint inhibitorsKevin Tyan, Joanna Baginska, Martha Brainard, et al.
Journal of Translational Medicine|December 17, 2014
Pre-immature dendritic cells (PIDC) pulsed with HPV16 E6 or E7 peptide are capable of eliciting specific immune response in patients with advanced cervical cancerOsama E Rahma, Vincent E Herrin, Rami A Ibrahim, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 30, 2021
Myeloid Cell Infiltration Correlates With Prognosis in Cholangiocarcinoma and Varies Based on Tumor LocationPaul R Kunk, Sean C Dougherty, Kevin Lynch, et al.
Journal of Translational Medicine|January 30, 2010
A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic renal cell carcinomaOsama E Rahma, Ed Ashtar, Ramy Ibrahim, et al.
JCO Oncology Practice|May 14, 2020
Safety of Immune Checkpoint Inhibitors in Patients With Pre-Existing Inflammatory Bowel Disease and Microscopic ColitisShilpa Grover, Alex B Ruan, Padmavathi Srivoleti, et al.
Journal for Immunotherapy of Cancer|March 10, 2022
Phase IB study of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumorsOsama E Rahma, Kevin Tyan, Anita Giobbie-Hurder, et al.
The Oncologist|May 16, 2019
Anti-PD-1 Immunotherapy-Induced Flare of a Known Underlying Relapsing Vasculitis Mimicking Recurrent CancerChristopher S Nabel, Mariano Severgnini, Yin P Hung, et al.
Pageof 6